caffeic acid phenethyl ester has been researched along with Neurofibromatosis 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celli, N; Demestre, M; Kluwe, L; Maruta, H; Mautner, V; Messerli, SM; Shahhossini, M | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and Neurofibromatosis 2
| Article | Year |
|---|---|
CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice.
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Cell Line, Tumor; Female; Humans; Mice; Mice, Nude; Neurofibromatosis 1; Neurofibromatosis 2; p21-Activated Kinases; Phenylethyl Alcohol; Propolis; Xenograft Model Antitumor Assays | 2009 |